Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)

被引:52
作者
Bosch, Megan E. [1 ]
Aldrich, Amy [2 ]
Fallet, Rachel [2 ]
Odvody, Jessica [2 ]
Burkovetskaya, Maria [2 ]
Schuberth, Kaitlyn [1 ]
Fitzgerald, Julie A. [3 ]
Foust, Kevin D. [3 ]
Kielian, Tammy [2 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, 985900 Nebraska Med Ctr, Omaha, NE 68198 USA
[3] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
关键词
AAV9; astrocyte; Batten disease; CLN3; lysosomal storage disease; microglia; CENTRAL-NERVOUS-SYSTEM; MITOCHONDRIAL ATP SYNTHASE; BATTEN-DISEASE PROTEIN; MOUSE MODEL; LYSOSOMAL STORAGE; RETT-SYNDROME; CELL-DEATH; SUBUNIT-C; MICE; MECP2;
D O I
10.1523/JNEUROSCI.1635-16.2016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Juvenile neuronal ceroid lipofuscinosis (JNCL) is a fatal lysosomal storage disease caused by autosomal-recessive mutations in CLN3 for which no treatment exists. Symptoms appear between 5 and 10 years of age, beginning with blindness and seizures, followed by progressive cognitive and motor decline and premature death (late teens to 20s). We explored a gene delivery approach for JNCL by generating two self-complementary adeno-associated virus 9 (scAAV9) constructs to address CLN3 dosage effects using the methyl-CpG-binding protein 2 (MeCP2) and beta-actin promoters to drive low versus high transgene expression, respectively. This approach was based on the expectation that low CLN3 levels are required for cellular homeostasis due to minimal CLN3 expression postnatally, although this had not yet been demonstrated in vivo. One-month-old Cln3(Delta ex7/8) mice received one systemic (intravenous) injection of scAAV9/MeCP2-hCLN3 or scAAV9/beta-actin-hCLN3, with green fluorescent protein (GFP)-expressing viruses as controls. Apromoter-dosage effect was observed in all brain regions examined, in which hCLN3 levels were elevated 3- to 8-fold in Cln3(Delta ex7/8) mice receiving scAAV9/beta-actin-hCLN3 versus scAAV9/MeCP2-hCLN3. However, a disconnect occurred between CLN3 levels and disease improvement, because only the scAAV9 construct driving low CLN3 expression (scAAV9/MeCP2-hCLN3) corrected motor deficits and attenuated microglial and astrocyte activation and lysosomal pathology. This may have resulted from preferential promoter usage because transgene expression after intravenous scAAV9/MeCP2-GFP injection was primarily detected in NeuN(+) neurons, whereas scAAV9/beta-actin-GFP drove transgene expression in GFAP(+) astrocytes. This is the first demonstration of a systemic delivery route to restore CLN3 in vivo using scAAV9 and highlights the importance of promoter selection for disease modification in juvenile animals.
引用
收藏
页码:9669 / 9682
页数:14
相关论文
共 71 条
[1]   Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms [J].
Åberg, L ;
Liewendahl, K ;
Nikkinen, P ;
Autti, T ;
Rinne, JO ;
Santavuori, P .
NEUROLOGY, 2000, 54 (05) :1069-1074
[2]   Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness [J].
Acland, GM ;
Aguirre, GD ;
Bennett, J ;
Aleman, TS ;
Cideciyan, AV ;
Bennicelli, J ;
Dejneka, NS ;
Pearce-Kelling, SE ;
Maguire, AM ;
Palczewski, K ;
Hauswirth, WW ;
Jacobson, SG .
MOLECULAR THERAPY, 2005, 12 (06) :1072-1082
[3]   A segment of the Mecp2 promoter is sufficient to drive expression in neurons [J].
Adachi, M ;
Keefer, EW ;
Jones, FS .
HUMAN MOLECULAR GENETICS, 2005, 14 (23) :3709-3722
[4]   Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain [J].
Aschauer, Dominik F. ;
Kreuz, Sebastian ;
Rumpel, Simon .
PLOS ONE, 2013, 8 (09)
[5]  
Autti T, 1996, NEURORADIOLOGY, V38, P476
[6]   Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology [J].
Ballas, Nurit ;
Lioy, Daniel T. ;
Grunseich, Christopher ;
Mandel, Gail .
NATURE NEUROSCIENCE, 2009, 12 (03) :311-317
[7]   Drosophila Neuroligin 1 Promotes Growth and Postsynaptic Differentiation at Glutamatergic Neuromuscular Junctions [J].
Banovic, Daniel ;
Khorramshahi, Omid ;
Owald, David ;
Wichmann, Carolin ;
Riedt, Tamara ;
Fouquet, Wernher ;
Tian, Rui ;
Sigrist, Stephan J. ;
Aberle, Hermann .
NEURON, 2010, 66 (05) :724-738
[8]   A Single Intravenous AAV9 Injection Mediates Bilateral Gene Transfer to the Adult Mouse Retina [J].
Bemelmans, Alexis-Pierre ;
Duque, Sandra ;
Riviere, Christel ;
Astord, Stephanie ;
Desrosiers, Melissa ;
Marais, Thibault ;
Sahel, Jose-Alain ;
Voit, Thomas ;
Barkats, Martine .
PLOS ONE, 2013, 8 (04)
[9]   Neuroinflammatory paradigms in lysosomal storage diseases [J].
Bosch, Megan E. ;
Kielian, Tammy .
FRONTIERS IN NEUROSCIENCE, 2015, 9
[10]   MOTOR-NEURON DEGENERATION OF MICE IS A MODEL OF NEURONAL CEROID LIPOFUSCINOSIS (BATTENS DISEASE) [J].
BRONSON, RT ;
LAKE, BD ;
COOK, S ;
TAYLOR, S ;
DAVISSON, MT .
ANNALS OF NEUROLOGY, 1993, 33 (04) :381-385